Natco Pharma
Mylan wins patent battle over sclerosis drug Copaxone
26 August 2016
Natco gets USFDA approval for generic version of Roche’s influenza drug Tamiflu
06 August 2016
Natco, partner settle patent suit over Gilead’s Tamiflu
15 December 2015
Natco to sell generic hepatitis C drug at Rs710 per tablet
12 March 2015
Gilead's patent for hepatitis C drug Sofosbuvir rejected in India
16 January 2015
Natco Pharma opposes Indian patent for Gilead’s hepatitis drug
11 April 2014
Delhi HC bars export of Natco's generic cancer drug on Bayer’s plea
27 March 2014
Bayer appeals against grant of ‘Nexavar’ licence to Natco
07 May 2012
Natco granted compulsory licence for Bayer's Nexavar
12 March 2012
Ministry stays DCGI ban on Natco's generic cancer drug
11 January 2010
Natco Pharma launches H1N1 drug ‘Natflu’
18 September 2009
Natco, Dr Reddy’s tie up for cancer generics
16 April 2009
Natco Pharma grants global marketing for its generic Copaxone to Mylan
10 June 2008
Natco Pharma acquires 75 per cent in US retail store
31 January 2006
Natco Pharma finalises terms for supply of two onco formulations
20 December 2005
Natco Pharma unveils new drug
26 June 2004
 search domain-b